Silver Book Fact

Therapy that keeps blood glucose levels as close to normal as possible in type 1 diabetics, reduces damage to the kidneys by 35-56%. Experts believe that these results can be applied to type 2 diabetics.

Lasker R. The Diabetes Control and Complications Trial: Implications for policy and practice. NEJM. 1993; 329: 1035-6. http://www.nejm.org/doi/full/10.1056/NEJM199309303291410

Reference

Title
The Diabetes Control and Complications Trial: Implications for policy and practice
Publication
NEJM
Publication Date
1993
Authors
Lasker R
Pages
1035-6
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • During the first year of a community pharmacy services program in 2003 which included 256 diabetes patients who used scheduled consultations, clinical goal setting, monitoring and collaborative drug therapy management…  
  • New and emerging technologies have made it easier for people with diabetes to manage their disease. Improved technology came in the form of a continuous glucose monitor, first approved by…  
  • Anti-VEGF Letter Improvement
    An anti-VEGF therapy for DME improved vision by more than 15 letters in approximately 36-51% of participants in a trial.  
  • Therapy that keeps blood glucose levels as close to normal as possible in type 1 diabetics, reduces damage to the kidneys by 35-56%. Experts believe that these results can be…  
  • Anti-VEGF Visual Improvement
    Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.